In patients with hepatocellular carcinoma, the number of CD45+CD71+ erythroid cells in peripheral blood was significantly elevated compared with healthy subjects and patients with chronic hepatitis B (Figure 2). This evidence concerns the gene PTPRC and hepatocellular carcinoma.